These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35622909)

  • 1. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature.
    Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
    Sci Adv; 2022 May; 8(21):eabo5083. PubMed ID: 35622909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and X-ray diffraction at room temperature.
    Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
    bioRxiv; 2022 Feb; ():. PubMed ID: 35169801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
    Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
    bioRxiv; 2020 Oct; ():. PubMed ID: 32511412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
    Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
    Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of a highly conserved isoleucine residue in loop 2 of several β-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.
    Kerr CM; Pfannenstiel JJ; Alhammad YM; O'Connor JJ; Ghimire R; Shrestha R; Khattabi R; Saenjamsai P; Parthasarathy S; McDonald PR; Gao P; Johnson DK; More S; Roy A; Channappanavar R; Fehr AR
    J Virol; 2024 Nov; 98(11):e0131324. PubMed ID: 39387584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
    Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.
    Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
    Bioorg Med Chem; 2022 Aug; 67():116788. PubMed ID: 35597097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.
    Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
    J Virol; 2021 Jul; 95(15):e0076621. PubMed ID: 34011547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.
    Roy A; Alhammad YM; McDonald P; Johnson DK; Zhuo J; Wazir S; Ferraris D; Lehtiö L; Leung AKL; Fehr AR
    Antiviral Res; 2022 Jul; 203():105344. PubMed ID: 35598780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of a highly conserved isoleucine residue in loop 2 of several
    Kerr CM; Pfannenstiel JJ; Alhammad YM; O'Connor JJ; Ghimire R; Shrestha R; Khattabi R; Saenjamsai P; Parthasarathy S; McDonald PR; Gao P; Johnson DK; More S; Roy A; Channappanavar R; Fehr AR
    bioRxiv; 2024 Jul; ():. PubMed ID: 38260573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
    Michalska K; Kim Y; Jedrzejczak R; Maltseva NI; Stols L; Endres M; Joachimiak A
    IUCrJ; 2020 Sep; 7(Pt 5):814-824. PubMed ID: 32939273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2.
    Gahbauer S; Correy GJ; Schuller M; Ferla MP; Doruk YU; Rachman M; Wu T; Diolaiti M; Wang S; Neitz RJ; Fearon D; Radchenko D; Moroz Y; Irwin JJ; Renslo AR; Taylor JC; Gestwicki JE; von Delft F; Ashworth A; Ahel I; Shoichet BK; Fraser JS
    bioRxiv; 2022 Jul; ():. PubMed ID: 35794891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
    Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
    J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors.
    O'Connor JJ; Ferraris D; Fehr AR
    Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2.
    Gahbauer S; Correy GJ; Schuller M; Ferla MP; Doruk YU; Rachman M; Wu T; Diolaiti M; Wang S; Neitz RJ; Fearon D; Radchenko DS; Moroz YS; Irwin JJ; Renslo AR; Taylor JC; Gestwicki JE; von Delft F; Ashworth A; Ahel I; Shoichet BK; Fraser JS
    Proc Natl Acad Sci U S A; 2023 Jan; 120(2):e2212931120. PubMed ID: 36598939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
    Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y
    J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An MHV macrodomain mutant predicted to lack ADP-ribose binding activity is severely attenuated, indicating multiple roles for the macrodomain in coronavirus replication.
    Voth LS; O'Connor JJ; Kerr CM; Doerger E; Schwarting N; Sperstad P; Johnson DK; Fehr AR
    bioRxiv; 2021 Mar; ():. PubMed ID: 33821264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Evaluation of Inhibitors of the SARS-CoV2 nsp3 Macrodomain.
    Sherrill LM; Joya EE; Walker A; Roy A; Alhammad YM; Atobatele M; Wazir S; Abbas G; Keane P; Zhuo J; Leung AKL; Johnson DK; Lehtiö L; Fehr AR; Ferraris D
    bioRxiv; 2022 Feb; ():. PubMed ID: 35262078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.